PE regimen: Clinical Trials

7 trials of PE regimen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown, 1 active not recruiting. 7 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 4, Unknown 2, Active not recruiting 1
Phase 21Unknown 1

Follow PE regimen: new trials by email Literature Review of PE regimen trials Research Report on PE regimen

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer
HLX10, carboplatin/cisplatin-etoposide, Thoracic radiotherapy - Limited-Stage Small Cell Lung Cancer
Phase 3Active not recruitingShanghai Henlius Biotech5112022-05-172026-01-13
Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma
Simmtecan, 5-FU and l-LV, Toripalimab, Etoposide, Cisplatin - Neuroendocrine Carcinoma of the Bladder
Phase 2 / Phase 3UnknownPeking University3362019-06-192019-06-20
Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer
Durvalumab, Placebo, Cisplatin/ Etoposide - Non-Small Cell Lung Cancer
Phase 3CompletedAstraZeneca3282018-03-292026-07-14
A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer
cisplatin, etoposide, cisplatin, etoposide, apatinib - Progression Free Survival
Phase 3UnknownQingdao University1202017-03-012017-04-04
Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer
Etoposide + cisplatin, Irinotecan + cisplatin - Small Cell Lung Carcinoma
Phase 3CompletedPfizer4852002-06-012010-02-18
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults
topotecan/cisplatin, etoposide/cisplatin - Small Cell Lung Cancer
Phase 3CompletedGlaxoSmithKline7602001-04-012013-08-21
Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer
Cisplatin + etoposide, Epirubicin + ifosfamide + etoposide - Small Cell Lung Carcinoma, Extensive Disease
Phase 3CompletedEuropean Lung Cancer Working Party3612000-04-012015-02-12

Conditions studied

Small Cell Lung Carcinoma (4)  ·  Carcinoma (1)  ·  Carcinoma, Neuroendocrine (1)  ·  Carcinoma, Non-Small-Cell Lung (1)

Sponsors

AstraZeneca (1)  ·  European Lung Cancer Working Party (1)  ·  GlaxoSmithKline (1)  ·  Peking University (1)  ·  Pfizer (1)  ·  Qingdao University (1)  ·  Shanghai Henlius Biotech (1)

Countries

China (4)  ·  Czechia (4)  ·  Poland (4)  ·  Spain (4)  ·  Austria (3)  ·  Belgium (3)  ·  France (3)  ·  Germany (3)  ·  Hungary (3)  ·  Netherlands (3)  ·  Russia (3)  ·  Brazil (2)  ·  Greece (2)  ·  Italy (2)  ·  Mexico (2)

Top investigators

Jean-Paul Sculier, MD, PhD (1)  ·  Jeffrey Bradley, MD (1)  ·  Jinming Yu, MD (1)  ·  Lin Shen (1)  ·  Ying Cheng (1)  ·  Zhuang Yu, MD, Ph. D (1)

Results publications

PMID 28975084

NIH funding

2017 (1)